Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
MMWR. Morbidity and Mortality Weekly Report|March 21, 2014
Trends in tuberculosis - United States, 2013Negar Niki Alami, Courtney M Yuen, Roque Miramontes, et al.
Ebiomedicine|May 30, 2025
Role of human infection challenge studies (HICs) in drug development for respiratory syncytial virus (RSV): systematic review and meta-analysisProsenjit Kundu, Mark Quinn, Elaine Thomas, et al.
Open Forum Infectious Diseases|January 9, 2026
Orolabial and Genital Herpes Clinical Trials: A Meta-analysis of EndpointsAbigail Sloan, Mahta Mortezavi, Jacqueline Gerhart, et al.
Infectious Diseases and Therapy|March 10, 2024
Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT)Olga Sánchez-Soliño, Ryan D Kilpatrick, Christopher Johnson, et al.
Infectious Diseases and Therapy|February 2, 2022
EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance StudyRyan D Kilpatrick, Olga Sánchez-Soliño, Negar Niki Alami, et al.
Clinical and Translational Science|July 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging StudyRavi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 1, 2026
Utilizing Virtual Clinical Trials to Inform Target Coverage That Drives RSV Antiviral EfficacyJ Cody Herron, Kathryn G Link, Natalie Meacham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2024
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, et al.
Health Science Reports|April 3, 2019
Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)Tarik Asselah, Negar Niki Alami, Christophe Moreno, et al.
Gut and Liver|May 31, 2021
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III TrialsJeong Heo, Yoon Jun Kim, Jin-Woo Lee, et al.
Pageof 2